Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|December 15, 2020
Sepsis Management in Prolonged Field Care: 28 October 2020Justin Rapp, Sean Keenan, Daniel Taylor, et al.Arhiv Za Higijenu Rada I Toksikologiju|April 25, 2013
Exposure to urban air pollution and bone health in clinically healthy six-year-old childrenLilian Calderón-Garcidueñas, Antonieta Mora-Tiscareño, Maricela Francolira, et al.Journal of Alzheimer'S Disease : JAD|September 30, 2011
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adultsLilian Calderón-Garcidueñas, Michael Kavanaugh, Michelle Block, et al.Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteomeHongbing Zhang, Lily I Pao, Aileen Zhou, et al.Cancer Research|September 16, 2022
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited ToxicityLeila M Boustany, Sherry L LaPorte, Laurie Wong, et al.Science Translational Medicine|March 29, 2013
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancerThomas C Harding, Li Long, Servando Palencia, et al.The Prostate|March 19, 2025
Outcome of Subsequent Therapies After <sup>177</sup>Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center ExperienceMeryam Losee, Michael Kavanaugh, Mofei Liu, et al.Cancer Immunology Research|October 12, 2021
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 AgentsHikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.Molecular Cancer Therapeutics|June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug ConjugateShweta Singh, Laura Serwer, Amy DuPage, et al.Pageof 4